A 52-year-old jogger collapses on his morning run and is found unresponsive without a pulse. How hands-only CPR saved his ...
The Apple Watch Series 4's transformation from miniature iPhone and fitness tracker to medical device is now complete with the release of the ECG (electrocardiogram) app and irregular heart rhythm ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Awarded by the Project Management Institute (PMI), the ...
Large-scale study reveals 'flat-line ECG' indicates poor outcomes for out-of-hospital cardiac arrest
Asystole is the most serious form of cardiac arrest. It happens when the heart stops beating and there is no more electrical activity. It is sometimes called "flat-line" or "flat-lining" because the ...
Rhythm has just completed the final full system validation of its ColoSTAT, a diagnostic test for colorectal cancer. Dr Feber explains how ColoSTAT could be used in clinics, explains the strong ...
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Rhythm has just completed the final full system validation of its ColoSTAT, a diagnostic test for ...
Rhythm Biosciences enters co-marketing deal with Know Your Lemons Foundation, a global non-profit organisation dedicated to breast cancer education and early detection. Under the deal Rhythm ...
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Rhythm completes final full system validation of ColoSTAT for the kits, algorithm and instrumentation ...
The test is meant to filter out teachers who hold views “antithetical” to Oklahoma values. By Jonathan Wolfe Oklahoma will require teachers coming from New York and California to pass a test to combat ...
A new test will be administered to out-of-state teachers coming to Oklahoma from blue states in a move the state superintendent said is meant to root out “radical leftist ideology” from classrooms.
Rhythm Biosciences undertakes a capital raise of up to $3.75m to advance development of its products, including a simple blood test to detect colorectal cancer. Special Report: Rhythm Biosciences is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results